PeptiDream Inc (PPTDF)
9.50
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
PeptiDream Price to Book Value: 4.303 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.303 |
| April 24, 2024 | 4.303 |
| April 23, 2024 | 4.303 |
| April 22, 2024 | 4.303 |
| April 19, 2024 | 4.303 |
| April 18, 2024 | 4.303 |
| April 17, 2024 | 4.303 |
| April 16, 2024 | 4.303 |
| April 15, 2024 | 4.303 |
| April 12, 2024 | 4.303 |
| April 11, 2024 | 4.303 |
| April 10, 2024 | 4.303 |
| April 09, 2024 | 4.303 |
| April 08, 2024 | 4.303 |
| April 05, 2024 | 4.303 |
| April 04, 2024 | 4.303 |
| April 03, 2024 | 4.303 |
| April 02, 2024 | 4.303 |
| April 01, 2024 | 4.303 |
| March 28, 2024 | 4.303 |
| March 27, 2024 | 4.303 |
| March 26, 2024 | 4.303 |
| March 25, 2024 | 4.303 |
| March 22, 2024 | 4.303 |
| March 21, 2024 | 4.303 |
| Date | Value |
|---|---|
| March 20, 2024 | 4.303 |
| March 19, 2024 | 4.303 |
| March 18, 2024 | 4.303 |
| March 15, 2024 | 4.303 |
| March 14, 2024 | 4.303 |
| March 13, 2024 | 4.303 |
| March 12, 2024 | 4.303 |
| March 11, 2024 | 4.303 |
| March 08, 2024 | 4.303 |
| March 07, 2024 | 4.303 |
| March 06, 2024 | 3.878 |
| March 05, 2024 | 3.878 |
| March 04, 2024 | 3.878 |
| March 01, 2024 | 3.878 |
| February 29, 2024 | 3.878 |
| February 28, 2024 | 3.878 |
| February 27, 2024 | 3.878 |
| February 26, 2024 | 3.878 |
| February 23, 2024 | 3.878 |
| February 22, 2024 | 3.878 |
| February 21, 2024 | 3.878 |
| February 20, 2024 | 3.878 |
| February 16, 2024 | 3.878 |
| February 15, 2024 | 3.878 |
| February 14, 2024 | 3.878 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.831
Minimum
Oct 31 2023
48.64
Maximum
May 10 2019
20.52
Average
13.82
Median
Oct 14 2021
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8556 |
| Nxera Pharma Co Ltd | 1.756 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
| AnGes Inc | 0.3645 |
Price to Book Value Related Metrics
| PE Ratio | 59.38 |
| PS Ratio | 6.082 |
| Price to Free Cash Flow | 15.65 |
| Price | 9.50 |
| Earnings Yield | 1.68% |
| Market Cap | 1.231B |
| Operating PE Ratio | 26.54 |
| Normalized PE Ratio | 59.38 |